Feasibility of a Mindfulness Intervention for Endometriosis Surgery

December 9, 2025 updated by: Christa Coleman, Milton S. Hershey Medical Center
Endometriosis is a common cause of pelvic pain in women which has been historically under-studied and under-diagnosed. The goal of this research is to pilot-test the feasibility and acceptability of a manualized, single-session brief mindfulness-based intervention (BMBI) among participants with endometriosis-related chronic pelvic pain (ECPP) who undergo surgical treatment, and gather preliminary data necessary for future studies assessing BMBI's impact on outcomes in surgically-treated ECPP. This pilot study will enroll 10-20 adult participants with ECPP to receive either a BMBI adjunctive to treatment as usual (TAU; n=5-10) or education with TAU (n=5-10) prior to their ECPP surgery. The central hypothesis is the BMBI is feasible to deliver pre-operatively, acceptable to patients, and may help improve acute post-surgical outcomes through more adaptive stress coping and pain processing, enabled by mindfulness training.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. age 18 years or older
  2. diagnosis or probable diagnosis of endometriosis
  3. candidate for surgical procedure for endometriosis
  4. English speaking
  5. have access to wifi and email

Exclusion Criteria:

  1. prior formal mindfulness training
  2. Unable to consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard of care for endometriosis surgery plus education
Pain education
Experimental: Standard of care for endometriosis surgery plus mindfulness
Brief mindfulness of pain introduction and intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Use of opioid medication
Time Frame: 1 week
Morphine milligram equivalent following surgery
1 week
Use of opioid medication
Time Frame: 3 months
Morphine milligram equivalent following surgery
3 months
Pain intensity
Time Frame: 1 week
Numerical Pain Rating Scale 0-10, 10 being highest
1 week
Pain intensity
Time Frame: 3 months
Numerical Pain Rating Scale 0-10, 10 being highest
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep report
Time Frame: 1 week following surgery
sleep diary (hours slept, activities during day and night)
1 week following surgery
Sleep report
Time Frame: 1 week prior to surgery
sleep diary (hours slept, activities during day and night)
1 week prior to surgery
Emotional functioning
Time Frame: baseline
Hospital Anxiety and Depression Scale 0-21, 21 is worst
baseline
Emotional functioning
Time Frame: 1 week
Hospital Anxiety and Depression Scale 0-21, 21 is worst
1 week
Emotional functioning
Time Frame: 3 months
Hospital Anxiety and Depression Scale 0-21, 21 is worst
3 months
Patient global impression of change
Time Frame: 3 months
Global Impression of change 1-7, 1 is best
3 months
Patient global impression of change
Time Frame: 1 week
Global Impression of change 1-7, 1 is best
1 week
Pain catastrophizing
Time Frame: baseline
Pain catastrophizing Scale 0-52, 52 is worst
baseline
Pain catastrophizing
Time Frame: 1 week
Pain catastrophizing Scale 0-52, 52 is worst
1 week
Pain catastrophizing
Time Frame: 3 months
Pain catastrophizing Scale 0-52, 52 is worst
3 months
Treatment satisfaction
Time Frame: 1 week
Treatment satisfaction 0-10, 10 being best
1 week
Treatment satisfaction
Time Frame: 3 months
Treatment satisfaction 0-10, 10 being best
3 months
Sleep quality (sleep duration, awakenings, efficiency)
Time Frame: 1 week prior to surgery
actigraphy monitoring
1 week prior to surgery
Sleep quality (sleep duration, awakenings, efficiency)
Time Frame: 1 week following surgery
actigraphy monitoring
1 week following surgery
Heart rate variability
Time Frame: baseline
brief HRV assessment baseline and during intervention
baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain threshold
Time Frame: baseline
Pain threshold
baseline
Temporal summation
Time Frame: baseline
Temporal summation of pain
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christa Coleman, Penn State Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

November 15, 2023

First Submitted That Met QC Criteria

November 15, 2023

First Posted (Actual)

November 21, 2023

Study Record Updates

Last Update Posted (Estimated)

December 17, 2025

Last Update Submitted That Met QC Criteria

December 9, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on pain education

Subscribe